<DOC>
	<DOCNO>NCT02194335</DOCNO>
	<brief_summary>The objective present study obtain information safety , tolerability pharmacokinetics BIBN 4096 BS oral administration increase dos healthy male female volunteer . With respect pharmacokinetics , particular importance investigate whether therapeutic plasma level ( treatment migraine ) could achieve oral administration BIBN 4096 BS formulation .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetics Increasing Doses BIBN 4096 BS Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<criteria>Participants healthy male female Age range 21 50 year Broca Index : within + 20 % normal weight Subsequently subject medical history take receive complete medical examination ( incl . blood pressure pulse rate measurement ) well 12lead Electrocardiogram ( ECG ) . Hematopoietic , hepatic renal function test carry laboratory . The subject fast 12 hour collection specimens laboratory evaluation . The mentioned examination perform within 14 day first administration test substance . In accordance Good Clinical Practice ( GCP ) local legislation volunteer give write informed consent prior admission study Any finding medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) within least one month less ten halflives respective drug enrolment study ( exclusion : substitution therapy regard thyroid gland and/or ovary ) Use drug might influence result trial ( within one week prior administration trial ) Participation another study investigational drug within two month prior administration trial Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke study day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation ( &gt; = 100 ml ) within four week prior administration trial Excessive physical activity ( within last week study ) Any laboratory value outside reference range clinical relevance For female subject : Pregnancy Positive pregnancy test No adequate contraception e.g . oral contraceptive , sterilization , intrauterine pessary ( IUP ) Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>